NXL MEXC RealStocks
Own real NXL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 21:23:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Nexalin Technology, Inc. (NXL) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.53, with a market capitalization of $1.71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $39.30. This page covers its latest market performance, valuation, price trends and company information.
$1.71M | |
$1.36 | |
$1.68 | |
$1.36 | |
$1.49 | |
16.50K | |
1.05M | |
-- | |
$39.30 | |
$1.31 | |
-- | |
-- |
Nexalin Technology, Inc. (NXL) is trading at $1.48 in after-hours trading as of 2026-11-13 21:16:00, down 2.95% ($0.04) from the regular-session close of $1.53.
After-hours trading shows how investors are pricing NXL after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Nexalin Technology, Inc. (NXL) moved from $1.40 to $1.53, representing a gain of 8.93% ($0.13).
The stock traded between $1.31 and $1.68 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 21.98 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.6%
NXL is currently trading at $1.53, placing it 0.6% of the way from its 52-week low of $1.31 to its 52-week high of $39.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Nexalin Technology, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Mar 23, 2007 |
| Payment Date | Apr 16, 2007 |
| Dividend Per Share | $0.3125 |
Eligible investors can buy real shares of Nexalin Technology, Inc. (NXL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NXL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NXL shares and USD.
NXL Shares to USD
1.00 NXL shares = 1.525 USD
Calculations are estimates based on the latest available price and are for reference only.